Do analysts rate DYNT or RBOT?

Given Dynatronics' higher probable upside, research analysts clearly believe Dynatronics is more favorable than Vicarious Surgical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dynatronics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Vicarious Surgical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Do analysts recommend RBOT or BIOL?

Given BIOLASE's higher possible upside, analysts clearly believe BIOLASE is more favorable than Vicarious Surgical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vicarious Surgical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 BIOLASE 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is RBOT or BIOL more profitable?

Vicarious Surgical has a net margin of 0.00% compared to BIOLASE's net margin of -41.65%. Vicarious Surgical's return on equity of -184.13% beat BIOLASE's return on equity. Company Net Margins Return on Equity Return on Assets Vicarious Surgical N/A -184.13% -112.50% BIOLASE -41.65% -1,782.73% -55.31%

Do analysts prefer RBOT or VERO?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vicarious Surgical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Venus Concept 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend RBOT or SDCCQ?

Given SmileDirectClub's higher possible upside, analysts clearly believe SmileDirectClub is more favorable than Vicarious Surgical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vicarious Surgical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 SmileDirectClub 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is RBOT or SDCCQ more profitable?

SmileDirectClub's return on equity of 0.00% beat Vicarious Surgical's return on equity. Company Net Margins Return on Equity Return on Assets Vicarious Surgical N/A -184.13% -112.50% SmileDirectClub N/A N/A N/A

Do analysts recommend RBOT or SSKN?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vicarious Surgical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Strata Skin Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Vicarious Surgical (RBOT) Competitors

$0.04 0.00 (0.00%)

As of 08/28/2026 02:48 PM Eastern

Compare

RBOT vs. DYNT, BIOL, VERO, SDCCQ, and SSKN

Should you buy Vicarious Surgical stock or one of its competitors? Vicarious Surgical's main competitors and comparable companies include Dynatronics (DYNT), BIOLASE (BIOL), Venus Concept (VERO), SmileDirectClub (SDCCQ), and Strata Skin Sciences (SSKN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Vicarious Surgical compare to Dynatronics?

Dynatronics (NASDAQ:DYNT) and Vicarious Surgical (NYSE:RBOT) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, dividends, risk, profitability, institutional ownership and earnings.

Dynatronics has a beta of 0.31, suggesting that its share price is 69% less volatile than the broader market. Comparatively, Vicarious Surgical has a beta of 1.92, suggesting that its share price is 92% more volatile than the broader market.

Vicarious Surgical has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Dynatronics' return on equity of -41.81% beat Vicarious Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dynatronics	-8.35%	-41.81%	-9.56%
Vicarious Surgical	N/A	-184.13%	-112.50%

4.2% of Dynatronics shares are owned by institutional investors. Comparatively, 47.3% of Vicarious Surgical shares are owned by institutional investors. 2.9% of Dynatronics shares are owned by insiders. Comparatively, 11.1% of Vicarious Surgical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Dynatronics has higher revenue and earnings than Vicarious Surgical. Vicarious Surgical is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dynatronics	$33.60M	0.00	-$2.70M	-$1.35	N/A
Vicarious Surgical	N/A	N/A	-$63.22M	-$6.69	N/A

Given Dynatronics' higher probable upside, research analysts clearly believe Dynatronics is more favorable than Vicarious Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dynatronics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Vicarious Surgical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

In the previous week, Dynatronics' average media sentiment score of 0.00 equaled Vicarious Surgical'saverage media sentiment score.

Company	Overall Sentiment
Dynatronics	Neutral
Vicarious Surgical	Neutral

Summary

Dynatronics and Vicarious Surgical tied by winning 6 of the 12 factors compared between the two stocks.

How does Vicarious Surgical compare to BIOLASE?

Vicarious Surgical (NYSE:RBOT) and BIOLASE (NASDAQ:BIOL) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, media sentiment, risk, earnings, analyst recommendations, dividends and institutional ownership.

Given BIOLASE's higher possible upside, analysts clearly believe BIOLASE is more favorable than Vicarious Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vicarious Surgical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
BIOLASE	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

BIOLASE has higher revenue and earnings than Vicarious Surgical. Vicarious Surgical is trading at a lower price-to-earnings ratio than BIOLASE, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vicarious Surgical	N/A	N/A	-$63.22M	-$6.69	N/A
BIOLASE	$48.83M	0.00	-$20.63M	-$14.94	N/A

In the previous week, Vicarious Surgical's average media sentiment score of 0.00 equaled BIOLASE'saverage media sentiment score.

Company	Overall Sentiment
Vicarious Surgical	Neutral
BIOLASE	Neutral

47.3% of Vicarious Surgical shares are held by institutional investors. Comparatively, 8.8% of BIOLASE shares are held by institutional investors. 11.1% of Vicarious Surgical shares are held by company insiders. Comparatively, 0.3% of BIOLASE shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Vicarious Surgical has a net margin of 0.00% compared to BIOLASE's net margin of -41.65%. Vicarious Surgical's return on equity of -184.13% beat BIOLASE's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vicarious Surgical	N/A	-184.13%	-112.50%
BIOLASE	-41.65%	-1,782.73%	-55.31%

Vicarious Surgical has a beta of 1.92, meaning that its stock price is 92% more volatile than the broader market. Comparatively, BIOLASE has a beta of 0.67, meaning that its stock price is 33% less volatile than the broader market.

Summary

Vicarious Surgical beats BIOLASE on 7 of the 12 factors compared between the two stocks.

How does Vicarious Surgical compare to Venus Concept?

Vicarious Surgical (NYSE:RBOT) and Venus Concept (NASDAQ:VERO) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, media sentiment, analyst recommendations, institutional ownership, earnings, risk and profitability.

47.3% of Vicarious Surgical shares are owned by institutional investors. Comparatively, 87.4% of Venus Concept shares are owned by institutional investors. 11.1% of Vicarious Surgical shares are owned by insiders. Comparatively, 28.0% of Venus Concept shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Vicarious Surgical's average media sentiment score of 0.00 equaled Venus Concept'saverage media sentiment score.

Company	Overall Sentiment
Vicarious Surgical	Neutral
Venus Concept	Neutral

Venus Concept has higher revenue and earnings than Vicarious Surgical. Venus Concept is trading at a lower price-to-earnings ratio than Vicarious Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vicarious Surgical	N/A	N/A	-$63.22M	-$6.69	N/A
Venus Concept	$58.88M	0.01	-$47M	-$48.84	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vicarious Surgical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Venus Concept	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Vicarious Surgical has a beta of 1.92, suggesting that its share price is 92% more volatile than the broader market. Comparatively, Venus Concept has a beta of -0.06, suggesting that its share price is 106% less volatile than the broader market.

Vicarious Surgical has a net margin of 0.00% compared to Venus Concept's net margin of -92.76%. Vicarious Surgical's return on equity of -184.13% beat Venus Concept's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vicarious Surgical	N/A	-184.13%	-112.50%
Venus Concept	-92.76%	-1,904.25%	-85.22%

Summary

Vicarious Surgical beats Venus Concept on 6 of the 11 factors compared between the two stocks.

How does Vicarious Surgical compare to SmileDirectClub?

Vicarious Surgical (NYSE:RBOT) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and risk.

Vicarious Surgical has a beta of 1.92, meaning that its stock price is 92% more volatile than the broader market. Comparatively, SmileDirectClub has a beta of 1.31, meaning that its stock price is 31% more volatile than the broader market.

Vicarious Surgical has higher earnings, but lower revenue than SmileDirectClub. Vicarious Surgical is trading at a lower price-to-earnings ratio than SmileDirectClub, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vicarious Surgical	N/A	N/A	-$63.22M	-$6.69	N/A
SmileDirectClub	$470.74M	0.00	-$86.40M	-$0.13	N/A

47.3% of Vicarious Surgical shares are owned by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are owned by institutional investors. 11.1% of Vicarious Surgical shares are owned by company insiders. Comparatively, 64.7% of SmileDirectClub shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Vicarious Surgical's average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score.

Company	Overall Sentiment
Vicarious Surgical	Neutral
SmileDirectClub	Neutral

Given SmileDirectClub's higher possible upside, analysts clearly believe SmileDirectClub is more favorable than Vicarious Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vicarious Surgical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
SmileDirectClub	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

SmileDirectClub's return on equity of 0.00% beat Vicarious Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vicarious Surgical	N/A	-184.13%	-112.50%
SmileDirectClub	N/A	N/A	N/A

Summary

SmileDirectClub beats Vicarious Surgical on 7 of the 11 factors compared between the two stocks.

How does Vicarious Surgical compare to Strata Skin Sciences?

Vicarious Surgical (NYSE:RBOT) and Strata Skin Sciences (NASDAQ:SSKN) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, valuation, risk, media sentiment and profitability.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vicarious Surgical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Strata Skin Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Vicarious Surgical's average media sentiment score of 0.00 equaled Strata Skin Sciences'average media sentiment score.

Company	Overall Sentiment
Vicarious Surgical	Neutral
Strata Skin Sciences	Neutral

Vicarious Surgical has a beta of 1.92, indicating that its share price is 92% more volatile than the broader market. Comparatively, Strata Skin Sciences has a beta of 0.04, indicating that its share price is 96% less volatile than the broader market.

47.3% of Vicarious Surgical shares are owned by institutional investors. Comparatively, 32.4% of Strata Skin Sciences shares are owned by institutional investors. 11.1% of Vicarious Surgical shares are owned by company insiders. Comparatively, 40.9% of Strata Skin Sciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Strata Skin Sciences has higher revenue and earnings than Vicarious Surgical. Vicarious Surgical is trading at a lower price-to-earnings ratio than Strata Skin Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vicarious Surgical	N/A	N/A	-$63.22M	-$6.69	N/A
Strata Skin Sciences	$30.98M	0.00	-$10.09M	-$1.41	N/A

Vicarious Surgical has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. Vicarious Surgical's return on equity of -184.13% beat Strata Skin Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vicarious Surgical	N/A	-184.13%	-112.50%
Strata Skin Sciences	-35.64%	-476.73%	-33.49%

Summary

Strata Skin Sciences beats Vicarious Surgical on 6 of the 11 factors compared between the two stocks.

Get Vicarious Surgical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RBOT vs. The Competition

Export

Metric	Vicarious Surgical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$299K	$5.78B	$7.18B	$24.12B
Dividend Yield	N/A	1.75%	2.54%	3.72%
P/E Ratio	0.00	25.92	273.17	30.01
Price / Sales	N/A	78.92	638.13	16.90
Price / Cash	N/A	33.69	28.74	19.75
Price / Book	0.01	6.18	11.08	4.84
Net Income	-$63.22M	$149.94M	$3.48B	$1.07B
7 Day Performance	N/A	-0.70%	0.21%	-0.41%
1 Month Performance	N/A	5.99%	7.75%	2.04%
1 Year Performance	N/A	6.19%	24.68%	13.37%

Vicarious Surgical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RBOT Vicarious Surgical	N/A	$0.04 flat	N/A	-99.3%	$299K	N/A	N/A	210	Gap Down
DYNT Dynatronics	N/A	N/A	N/A	N/A	$653K	$33.60M	N/A	200
BIOL BIOLASE	N/A	N/A	N/A	N/A	$581K	$48.83M	N/A	160
VERO Venus Concept	N/A	$0.31 flat	N/A	N/A	$442K	$58.88M	N/A	410
SDCCQ SmileDirectClub	N/A	$0.00 +∞	N/A	N/A	$40K	$470.74M	N/A	2,700

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:RBOT) was last updated on 8/31/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Vicarious Surgical (RBOT) Competitors

RBOT vs. DYNT, BIOL, VERO, SDCCQ, and SSKN

How does Vicarious Surgical compare to Dynatronics?

Summary

How does Vicarious Surgical compare to BIOLASE?

Summary

How does Vicarious Surgical compare to Venus Concept?

Summary

How does Vicarious Surgical compare to SmileDirectClub?

Summary

How does Vicarious Surgical compare to Strata Skin Sciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RBOT vs. The Competition

Vicarious Surgical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Vicarious Surgical (RBOT) Competitors

RBOT vs. DYNT, BIOL, VERO, SDCCQ, and SSKN

How does Vicarious Surgical compare to Dynatronics?

Which has more volatility and risk, DYNT or RBOT?

Is DYNT or RBOT more profitable?

Do institutionals and insiders hold more shares of DYNT or RBOT?

Which has stronger valuation & earnings, DYNT or RBOT?

Do analysts rate DYNT or RBOT?

Does the media refer more to DYNT or RBOT?

Summary

How does Vicarious Surgical compare to BIOLASE?

Do analysts recommend RBOT or BIOL?

Which has stronger earnings & valuation, RBOT or BIOL?

Does the media refer more to RBOT or BIOL?

Do institutionals & insiders hold more shares of RBOT or BIOL?

Is RBOT or BIOL more profitable?

Which has more volatility and risk, RBOT or BIOL?

Summary

How does Vicarious Surgical compare to Venus Concept?

Do institutionals and insiders have more ownership in RBOT or VERO?

Does the media favor RBOT or VERO?

Which has stronger earnings & valuation, RBOT or VERO?

Do analysts prefer RBOT or VERO?

Which has more risk & volatility, RBOT or VERO?

Is RBOT or VERO more profitable?

Summary

How does Vicarious Surgical compare to SmileDirectClub?

Which has more volatility & risk, RBOT or SDCCQ?

Which has stronger valuation & earnings, RBOT or SDCCQ?

Do insiders & institutionals believe in RBOT or SDCCQ?

Does the media favor RBOT or SDCCQ?

Do analysts recommend RBOT or SDCCQ?

Is RBOT or SDCCQ more profitable?

Summary

How does Vicarious Surgical compare to Strata Skin Sciences?

Do analysts recommend RBOT or SSKN?

Does the media favor RBOT or SSKN?

Which has more volatility and risk, RBOT or SSKN?

Do insiders and institutionals have more ownership in RBOT or SSKN?

Which has better valuation & earnings, RBOT or SSKN?

Is RBOT or SSKN more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RBOT vs. The Competition

Vicarious Surgical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools